AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Microfluidics Market 2019-2029: Focus on Application, Type, End-user, Country Data (15 Countries), and Competitive Landscape - ResearchAndMarkets.com

January 3, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 3, 2020--

The “Global Microfluidics Market: Focus on Application, Type, End User, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029” report has been added to ResearchAndMarkets.com’s offering.

The global microfluidics industry analysis projects the market to grow at a significant CAGR of 13.73% during the forecast period, 2019-2029. The microfluidics market generated $10,260.6 million in revenue in 2018, in terms of value.

Microfluidics is significantly empowered by the rapid and continual advancements in technology. Owing to the explosion of molecular diagnostics and its applications, all areas of medicine have been significantly affected, with emphasis on point-of-care diagnostics. PCR has gradually evolved from gel analysis to real-time PCR to droplet microfluidics-based digital PCR in more recent times, depicting the increase in the evolutionary demands of the aligned industries.

Additionally, with key players in the market attempting to tackle several emerging diseases, technologies and consequently platforms, have become more refined. The rapid influx of technology within the industry has significantly propelled the entire microfluidics industry into becoming one of the most lucrative industries within the global healthcare market and more precisely, the global precision medicine market.

Expert Quote

This research strongly believes such technology will help to fill the gaps in existing immunoassay technology and be applied directly to biological samples such as blood, saliva, or urine.

Scope of the Market Intelligence

The microfluidics research provides a holistic view of the market in terms of various factors influencing it, including strategic developments and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with industrial and biological research. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global microfluidics market.

Key Companies

The key manufacturers who have been contributing significantly to the microfluidics market include 1CellBio Inc., Agilent Technologies Inc., Becton, Dickinson and Company, Cellix Ltd., Micronit Microtechnologies, Fluidigm Corporation, Perkin Elmer Inc., microfluidic Chipshop GmbH, Mission Bio, Merck KgaA, Sphere Fluidics, Thermo Fisher Scientific, Inc., Takara Bio Inc., Qiagen N.V. and uFluidix., among others.

Key Questions Answered

Key Topics Covered

Executive Summary

1 Research Scope and Methodology

2 Market Overview

2.1 Characteristics of Market Available Microfluidics Solutions

2.2 Microfluidics in Clinical Diagnostics

2.3 Global Footprint

3 Market Dynamics

3.1 Overview

3.2 Impact Analysis

3.3 Market Drivers

3.3.1 Growing Demand for Non-Invasive and Rapid Diagnosis

3.3.2 Increase in Adoption of Personalized Medicine Shifting the Paradigm from Reaction to Prevention on a Global Level

3.3.3 Significant External Funding for Executing Research and Development Exercises

3.3.4 Growing Demand for Point-of-Care Diagnostics

3.4 Market Restraints

3.4.1 Lack of Standardization

3.4.2 Lack of High Complexity Testing Centers

3.4.3 High Capital Requirement Hampering the Expansion of Global Reach

3.5 Market Opportunities

3.5.1 Massive Scope for Adoption of Microfluidics-based Solutions in Emerging Nations

3.5.2 Increased Use of Microfluidics in Widespread Applications

3.5.3 Hybridization of Technologies

4 Competitive Landscape

4.1 Key Strategies and Developments

4.1.1 Synergistic Activities

4.1.2 Funding and Expansion

4.1.3 Product Launches and Upgrades

4.1.4 Mergers and Acquisitions

5 Global Microfluidics Market (by Product Type)

5.1 Overview

5.2 Microfluidic Platforms

5.3 Microfluidic Chips

6 Global Microfluidics Market (by Application)

6.1 Overview

6.2 Point-of-Care Testing

6.3 Cell Analysis

6.4 Drug Development and Discovery

6.5 Organ-on-a-chip

6.6 Agro-Food Industry

6.7 Microbiological Research

6.8 Other

7 Global Microfluidics Market (by End User) 2018-2029

7.1 Overview

7.2 Research and Academic Laboratories

7.3 Biopharmaceutical and Biotech Companies

7.4 Diagnostic Centers

7.5 Other End Users

8 Global Microfluidics Market (by Region)

8.1 Overview

8.2 North America

8.3 Europe

8.4 Asia-Pacific

8.5 Latin America

8.6 Rest-of-the-World

9 Industry Insights

9.1 Market Share Analysis

9.2 Growth Share Analysis

10 Company Profiles

10.1 Overview

10.2 1CellBio, Inc.

10.3 Agilent Technologies, Inc.

10.4 Becton, Dickinson and Company

10.5 Cellix Ltd.

10.6 Fluidigm Corporation

10.7 Micronit MicroTechnologies

10.8 Illumina, Inc.

10.9 Merck KGaA

10.10 microfluidic ChipShop GmbH

10.11 Mission Bio

10.12 PerkinElemer, Inc.

10.13 Sphere Fluidics Limited

10.14 Thermo Fisher Scientific Inc.

10.15 Takara Bio Inc.

10.16 QIAGEN N.V.

10.17 uFluidix

For more information about this report visit https://www.researchandmarkets.com/r/po2n8x

View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005286/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: CHEMICALS/PLASTICS MANUFACTURING

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/03/2020 11:46 AM/DISC: 01/03/2020 11:46 AM

http://www.businesswire.com/news/home/20200103005286/en